HOME
SEARCH
RSS FEED
SUBSCRIBE
Search Results - e
1463
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
P
e
ptide Hydrogels for Delivery of Immunosuppressive Drugs and Uses Thereof
Summary: Th
e
National Cancer Institute (NCI) seeks research co-development partners and/or licensees for a hydrogel-based delivery system for the local administration of tofacitinib to improve transplant outcomes. Description of Technology: Unmet Need More than 1 million tissue transplantations are performed each year. Organ transplantation therapies...
Published: 11/6/2024
|
Inventor(s):
Giorgio Raimondi
,
Jo
e
l Schneider
,
Poulami Majumd
e
r
Keywords(s):
Category(s):
Application > Th
e
rapeutics
,
Collaboration Sought > Collaboration
,
Th
e
rapeuticArea > Immunology
,
Th
e
rapeuticArea > Cardiology
,
Th
e
rapeuticArea > Nephrology
HLA-class II-r
e
stricted T Cell Receptors for PIK3CA “Hotspot” Mutations, E545K and N345K
Summary: Th
e
National Cancer Institute (NCI) seeks co-development partners and/or licensees for a collection of T cell receptors (TCRs) that specifically target PIK3CA mutations to treat patients with tumors expressing these mutations in the context of HLA-DPA1*01:03:01, HLA-DPB1*04:01:01 or HLA-DRB1*04:01. Description of Technology: Phosphatidylinositol-4,5-biphosphate...
Published: 11/6/2024
|
Inventor(s):
St
e
ven Rosenberg
,
NIkolaos Zacharakis
,
S M Rafiqul Islam
,
Samantha S
e
itter
,
Maria Parkhurst
,
Frank Low
e
ry
Keywords(s):
Category(s):
Th
e
rapeuticArea
,
Th
e
rapeuticArea > Oncology
,
Th
e
rapeuticArea > Immunology
,
Collaboration Sought > Collaboration
,
Application > Th
e
rapeutics
Nov
e
l Kinase Inhibitory Thiazines
Summary Th
e
National Cancer Institute (NCI) seeks research co-development partners and/or licensees for a class of novel aplithianine-derived small molecule analogs that compete with ATP for binding on a range of clinically relevant kinases including: Oncogenic gene fusion DNAJB1-PRKACA (PKADJ) Wild type protein kinase A (PKA) Protein kinase...
Published: 11/4/2024
|
Inventor(s):
Barry O'K
e
efe
,
Lin Du
,
Bric
e
Wilson
,
Ping Zhang
,
William Moor
e
,
Dongdong Wang
,
Juliana Martin
e
z Fiesco
,
Ning Li
Keywords(s):
Category(s):
Application
,
Application > Th
e
rapeutics
,
Collaboration Sought > Collaboration
,
Th
e
rapeuticArea > Oncology
,
Th
e
rapeuticArea > Rare / Neglected Diseases
,
Th
e
rapeuticArea > Infectious Disease
Monoclonal Antibodi
e
s That Bind to the Underside of Influenza Viral Neuraminidase
Curr
e
nt influenza vaccines mainly induce antibodies against the surface glycoprotein hemagglutinin (HA) that block viral attachment to its host receptors and viral membrane fusion to the host cell. The immunodominant head region of HA undergoes antigenic drift and antibodies directed to the head confer little cross-protections between strains or subtypes. ...
Published: 10/31/2024
|
Inventor(s):
Masaru Kan
e
kiyo
,
Sarah Andr
e
ws
,
Julia L
e
derhofer
,
Yaroslav Tsybovsky
Keywords(s):
Category(s):
Application > Consum
e
r Products
,
Application > R
e
search Materials
,
Application > Th
e
rapeutics
,
Application > Vaccin
e
s
,
R
e
searchProducts > Antibodies
,
Th
e
rapeuticArea > Immunology
,
Th
e
rapeuticArea > Infectious Disease
R
e
verse Thiazine Kinase Inhibitors
Summary Th
e
National Cancer Institute (NCI) seeks research co-development partners and/or licensees for a class of novel aplithianine-derived small molecule analogs that compete with ATP for binding on a range of clinically relevant kinases including: Oncogenic gene fusion DNAJB1-PRKACA (PKADJ) Wild type protein kinase A (PKA) Protein kinase...
Published: 10/30/2024
|
Inventor(s):
Barry O'K
e
efe
,
Lin Du
,
Bric
e
Wilson
,
Ping Zhang
,
William Moor
e
,
Dongdong Wang
,
Juliana Martin
e
z Fiesco
,
Ning Li
Keywords(s):
Category(s):
Application > Th
e
rapeutics
,
Collaboration Sought > Collaboration
,
Th
e
rapeuticArea > Oncology
,
Th
e
rapeuticArea > Infectious Disease
,
Th
e
rapeuticArea > Rare / Neglected Diseases
Nov
e
l Kinase Inhibitory Aplithianines
Summary Th
e
National Cancer Institute (NCI) seeks research co-development partners and/or licensees for a class of novel aplithianine-derived small molecule analogs that compete with ATP for binding on a range of clinically relevant kinases including: Oncogenic gene fusion DNAJB1-PRKACA (PKADJ) Wild type protein kinase A (PKA) Protein kinase...
Published: 10/30/2024
|
Inventor(s):
Barry O'K
e
efe
,
Lin Du
,
Bric
e
Wilson
,
Ping Zhang
,
William Moor
e
,
Dongdong Wang
,
Juliana Martin
e
z Fiesco
,
Ning Li
Keywords(s):
Category(s):
Application > Th
e
rapeutics
,
Th
e
rapeuticArea > Oncology
,
Th
e
rapeuticArea > Infectious Disease
,
Th
e
rapeuticArea > Rare / Neglected Diseases
,
Collaboration Sought > Collaboration
Singl
e
Source-Detector Separation Approach to Calculate Tissue Oxygen Saturation
Summary: Th
e
National Institute of Child Health and Human Development (NICHD) seeks partners and/or licensees to further develop and commercialize the miniaturized tissue oximeter for implementing the single source-detector separation algorithm in existing devices/systems to collect tissue oxygen saturation. Description of Technology: Tissue oxygen...
Published: 10/2/2024
|
Inventor(s):
Thi
e
n Nguyen
,
Amir Gandjbakhch
e
,
Soongho Park
,
Brian Hill
Keywords(s):
Category(s):
Application > M
e
dical Devices
,
Th
e
rapeuticArea > Respiratory
,
Th
e
rapeuticArea > Neurology
,
Th
e
rapeuticArea > Infectious Disease
Oxynitidin
e
Derivatives Useful as Inhibitors of Topoisomerase IB (TOP1) and Tyrosyl-DNA Phosphodiesterase 1 (TDP1) for Treating Cancer
Summary: Th
e
National Cancer Institute (NCI) is actively seeking potential licensees and/or co-development research collaboration partners interested in advancing oxynitidine derivatives as novel inhibitors of topoisomerase IB (TOP1) and tyrosyl-DNA phosphodiesterase 1 (TDP1) for cancer treatment. These TOPI and TDP1 inhibitors, when administered...
Published: 9/18/2024
|
Inventor(s):
Yv
e
s Pommier
,
Lin-kun An
,
K
e
li Agama
,
E
vgeny Kiselev
,
Azhar Ravji
Keywords(s):
B
e
nzophenanthridine Derivatives
,
B
e
nzophenanthridinone
,
Camptoth
e
cin
,
Dihydrob
e
nzophenanthridine
,
IRINOT
E
CAN
,
Oxynitidin
e
,
Pommi
e
r
,
Tdp1
,
TOP1
,
Topoisom
e
rase 1B
,
Topot
e
can
,
Tyrosyl-DNA Phosphodi
e
sterase 1
Category(s):
Collaboration Sought > Lic
e
nsing
,
Collaboration Sought > Collaboration
,
Th
e
rapeuticArea > Oncology
,
Application > Th
e
rapeutics
Improv
e
d Methods For Cryopreservation Of Cells, Tissues, And Organs
Summary: Th
e
National Eye Institute seeks research co-development partners and/or licensees for novel methods of cryopreserving cells, tissues, and organs via FOXO1 activation and other mechanisms. Description of Technology: The cornea is a critical part of the eye that helps prevent debris from entering and refracts light for proper vision. Corneal...
Published: 9/9/2024
|
Inventor(s):
Jingxing Ou
,
Kiyoharu Miyagishima
,
Guanghui Jin
,
W
e
i Li
,
Lihao G
e
Keywords(s):
Category(s):
Application
,
Application > R
e
search Materials
,
Collaboration Sought > Collaboration
,
Th
e
rapeuticArea > Eye / Ear / Nose / Throat
Using Artificial Int
e
lligence To Diagnose Uveitis
Summary: Th
e
National Eye Institute seeks research co-development partners and/or licensees for a deep learning algorithm that can identify retinal vasculitis using color fundus images. Description of Technology: Uveitis is caused by inflammation in the eye that can cause pain and reduce vision. The rate of uveitis in the United States is 1 in every...
Published: 8/14/2024
|
Inventor(s):
Shilpa Kodati
,
Jongwoo Kim
,
Nam Nguy
e
n
Keywords(s):
Category(s):
Application > Diagnostics
,
Collaboration Sought > Collaboration
,
Th
e
rapeuticArea > Eye / Ear / Nose / Throat
1
2
3
4
5
6
7
8
9
10
...
Home
|
Search
|
RSS
|
Subscribe
© 2024. All Rights Reserved. Powered by
Inteum